Goodyear Tire & Rubber Co vs Nuwellis Inc — how do they compare? Goodyear Tire & Rubber Co trades at $4.73 (market cap $1.37B), while Nuwellis Inc trades at $0.7 (market cap $2.20M). The key difference: Goodyear Tire & Rubber Co is far larger — about 622.7× Nuwellis Inc's market cap, and Nuwellis Inc is more actively traded (121,544 versus 9,470,773). Which is the better fit depends on your goals — on Pluang, investors hold Goodyear Tire & Rubber Co for 57 Days and Nuwellis Inc for 26 Days on average.
| GT | NUWE | |
|---|---|---|
Market Cap | $1.37B | $2.20M |
Volume | 9,470,773 | 121,544 |
Sector | Consumer Cyclical | Health |
52-Week High | $10.54 | $146.65 |
52-Week Low | $4.66 | $0.68 |
Typical Hold Time | 57 Days | 26 Days |
Enterprise Value | $8.72B | -$1.52M |
Signals from Pluang's Aura AI — not financial advice
Goodyear Tire & Rubber (GT) trades at $4.69, up 0.64% on the day, but remains near 52-week lows amid a bearish technical outlook. The company reported a Q2 2026 loss of $0.61 per share, beating estimates but reflecting ongoing volume pressures. Revenue has declined from $20.8B in 2022 to $18.3B in 2025, with a net income margin of -14.37% in the latest period. Despite a low P/E of 4.69 and P/B of 0.48, negative ROE and ROA highlight profitability challenges. Recent news highlights a restructuring plan targeting margin improvement and debt reduction.
The outlook is mixed, with a consensus price target of $8.00 suggesting significant upside if restructuring succeeds. However, risks include persistent volume declines, high debt levels, and execution uncertainty. Analyst sentiment is cautious with 34.62% buy ratings, 50% hold, and 15.38% sell. Investors should weigh the deep value metrics against fundamental headwinds in the competitive tire industry.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.
Read more on GT →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →